Authors: Vermeersch, P Nong, Z Stabile, E Varenne, O Gillijns, H Pellens, M Van Pelt, N Hoylaerts, M De Scheerder, I Collen, D Janssens, S

Citation: P. Vermeersch et al., L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism, ART THROM V, 21(10), 2001, pp. 1604-1609

Authors: Vermylen, J Hoylaerts, M Arnout, J

Citation: J. Vermylen et al., Increased mortality with long-term platelet glycoprotein IIb/IIIa antagonists: An explanation?, CIRCULATION, 104(20), 2001, pp. E109-E109

Authors: Jacquemin, M Lavend'homme, R Benhida, A Vanzieleghem, B d'Oiron, R Lavergne, JM Brackmann, HH Schwaab, R VandenDriessche, T Chuah, MKL Hoylaerts, M Gilles, JGG Peerlinck, K Vermylen, J Saint-Remy, JMR

Citation: M. Jacquemin et al., A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor, BLOOD, 96(3), 2000, pp. 958-965

Authors: Gilles, JGG Lavend'homme, R Peerlinck, K Jacquemin, MG Hoylaerts, M Jorieux, S Mazurier, C Vermylen, J Saint-Remy, JMR

Citation: Jgg. Gilles et al., Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes, THROMB HAEM, 82(1), 1999, pp. 40-45